vs
ARGAN INC（AGX）与Apellis Pharmaceuticals, Inc.（APLS）财务数据对比。点击上方公司名可切换其他公司
ARGAN INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.3倍（$251.2M vs $199.9M），ARGAN INC净利率更高（12.2% vs -29.5%，领先41.7%），ARGAN INC同比增速更快（-2.3% vs -5.9%），ARGAN INC自由现金流更多（$171.9M vs $-14.3M），过去两年ARGAN INC的营收复合增速更高（23.5% vs 7.7%）
Argan Inc.是一家控股企业，主营工程设计、施工建设、项目管理及咨询服务，核心业务覆盖发电、电信、工业基建与可再生能源领域，主要服务北美地区的公营及私营部门客户。
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
AGX vs APLS — 直观对比
营收规模更大
AGX
是对方的1.3倍
$199.9M
营收增速更快
AGX
高出3.7%
-5.9%
净利率更高
AGX
高出41.7%
-29.5%
自由现金流更多
AGX
多$186.2M
$-14.3M
两年增速更快
AGX
近两年复合增速
7.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $251.2M | $199.9M |
| 净利润 | $30.7M | $-59.0M |
| 毛利率 | 18.7% | — |
| 营业利润率 | 13.0% | -25.6% |
| 净利率 | 12.2% | -29.5% |
| 营收同比 | -2.3% | -5.9% |
| 净利润同比 | 9.7% | -62.2% |
| 每股收益（稀释后） | $2.17 | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGXAPLS
| Q4 25 | $251.2M | $199.9M | ||
| Q3 25 | $237.7M | $458.6M | ||
| Q2 25 | $193.7M | $178.5M | ||
| Q1 25 | $232.5M | $166.8M | ||
| Q4 24 | $257.0M | $212.5M | ||
| Q3 24 | $227.0M | $196.8M | ||
| Q2 24 | $157.7M | $199.7M | ||
| Q1 24 | $164.6M | $172.3M |
净利润AGXAPLS
| Q4 25 | $30.7M | $-59.0M | ||
| Q3 25 | $35.3M | $215.7M | ||
| Q2 25 | $22.6M | $-42.2M | ||
| Q1 25 | $31.4M | $-92.2M | ||
| Q4 24 | $28.0M | $-36.4M | ||
| Q3 24 | $18.2M | $-57.4M | ||
| Q2 24 | $7.9M | $-37.7M | ||
| Q1 24 | $12.0M | $-66.4M |
毛利率AGXAPLS
| Q4 25 | 18.7% | — | ||
| Q3 25 | 18.6% | — | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 20.5% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | 14.4% | — |
营业利润率AGXAPLS
| Q4 25 | 13.0% | -25.6% | ||
| Q3 25 | 12.6% | 48.7% | ||
| Q2 25 | 12.6% | -18.6% | ||
| Q1 25 | 14.1% | -50.0% | ||
| Q4 24 | 11.8% | -12.3% | ||
| Q3 24 | 8.2% | -24.0% | ||
| Q2 24 | 4.1% | -14.7% | ||
| Q1 24 | 7.1% | -36.0% |
净利率AGXAPLS
| Q4 25 | 12.2% | -29.5% | ||
| Q3 25 | 14.8% | 47.0% | ||
| Q2 25 | 11.6% | -23.6% | ||
| Q1 25 | 13.5% | -55.3% | ||
| Q4 24 | 10.9% | -17.1% | ||
| Q3 24 | 8.0% | -29.2% | ||
| Q2 24 | 5.0% | -18.9% | ||
| Q1 24 | 7.3% | -38.5% |
每股收益（稀释后）AGXAPLS
| Q4 25 | $2.17 | $-0.40 | ||
| Q3 25 | $2.50 | $1.67 | ||
| Q2 25 | $1.60 | $-0.33 | ||
| Q1 25 | $2.26 | $-0.74 | ||
| Q4 24 | $2.00 | $-0.30 | ||
| Q3 24 | $1.31 | $-0.46 | ||
| Q2 24 | $0.58 | $-0.30 | ||
| Q1 24 | $0.89 | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | $466.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $419.7M | $370.1M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AGXAPLS
| Q4 25 | $423.7M | $466.2M | ||
| Q3 25 | $275.5M | $479.2M | ||
| Q2 25 | $304.3M | $370.0M | ||
| Q1 25 | $298.4M | $358.4M | ||
| Q4 24 | $299.8M | $411.3M | ||
| Q3 24 | $302.0M | $396.9M | ||
| Q2 24 | $291.8M | $360.1M | ||
| Q1 24 | $306.5M | $325.9M |
总债务AGXAPLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $93.1M |
股东权益AGXAPLS
| Q4 25 | $419.7M | $370.1M | ||
| Q3 25 | $393.2M | $401.2M | ||
| Q2 25 | $363.9M | $156.3M | ||
| Q1 25 | $351.9M | $164.2M | ||
| Q4 24 | $328.7M | $228.5M | ||
| Q3 24 | $308.1M | $237.1M | ||
| Q2 24 | $293.2M | $264.3M | ||
| Q1 24 | $290.9M | $266.7M |
总资产AGXAPLS
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $882.7M | $1.1B | ||
| Q2 25 | $792.2M | $821.4M | ||
| Q1 25 | $836.2M | $807.3M | ||
| Q4 24 | $768.9M | $885.1M | ||
| Q3 24 | $726.6M | $901.9M | ||
| Q2 24 | $624.4M | $904.5M | ||
| Q1 24 | $598.2M | $831.9M |
负债/权益比AGXAPLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.5M | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | $171.9M | $-14.3M |
| 自由现金流率自由现金流/营收 | 68.4% | -7.1% |
| 资本支出强度资本支出/营收 | 0.2% | 0.1% |
| 现金转化率经营现金流/净利润 | 5.61× | — |
| 过去12个月自由现金流最近4个季度 | $283.0M | $45.0M |
8季度趋势，按日历期对齐
经营现金流AGXAPLS
| Q4 25 | $172.5M | $-14.2M | ||
| Q3 25 | $34.6M | $108.5M | ||
| Q2 25 | $35.3M | $4.4M | ||
| Q1 25 | $44.6M | $-53.4M | ||
| Q4 24 | $31.8M | $19.4M | ||
| Q3 24 | $73.5M | $34.1M | ||
| Q2 24 | $17.7M | $-8.3M | ||
| Q1 24 | $24.6M | $-133.0M |
自由现金流AGXAPLS
| Q4 25 | $171.9M | $-14.3M | ||
| Q3 25 | $32.9M | $108.3M | ||
| Q2 25 | $34.9M | $4.4M | ||
| Q1 25 | $43.3M | $-53.4M | ||
| Q4 24 | $29.2M | $19.3M | ||
| Q3 24 | $71.1M | — | ||
| Q2 24 | $17.4M | $-8.4M | ||
| Q1 24 | $24.0M | $-133.3M |
自由现金流率AGXAPLS
| Q4 25 | 68.4% | -7.1% | ||
| Q3 25 | 13.8% | 23.6% | ||
| Q2 25 | 18.0% | 2.5% | ||
| Q1 25 | 18.6% | -32.0% | ||
| Q4 24 | 11.4% | 9.1% | ||
| Q3 24 | 31.3% | — | ||
| Q2 24 | 11.0% | -4.2% | ||
| Q1 24 | 14.6% | -77.3% |
资本支出强度AGXAPLS
| Q4 25 | 0.2% | 0.1% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.4% | 0.2% |
现金转化率AGXAPLS
| Q4 25 | 5.61× | — | ||
| Q3 25 | 0.98× | 0.50× | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.42× | — | ||
| Q4 24 | 1.13× | — | ||
| Q3 24 | 4.04× | — | ||
| Q2 24 | 2.24× | — | ||
| Q1 24 | 2.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGX
| Power Industry Services | $195.5M | 78% |
| Industrial Construction Services | $49.4M | 20% |
| Telecommunications Infrastructure Services | $6.3M | 3% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
